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TCT-616
Relationship Between Angiographic Dynamic and Densitometric Assessment of
Myocardial Reperfusion and Survival in Patients with Acute Myocardial
Infarction Treated with Primary Percutaneous Coronary Intervention: The
HORIZONS-AMI Trial
Sorin Jakob Brener1, 2, Ecaterina Cristea2, Roxana Mehran3, 2, Ovidiu Dressler2,
Alexandra J Lansky4, Gregg W Stone5, 2
1Medicine, NY Methodist Hospital, Brooklyn, NY; 2Cardiovascular Research
Foundation, New York, NY; 3Mount Sinai Medical center, New York, NY; 4Yale
University Medical center, New Haven, CT; 5Columbia University Medical center,
New York, NY
Background: Although primary percutaneous coronary intervention (PCI) restores
brisk epicardial flow in ~90% of patients with ST-segment elevation myocardial
infarction (STEMI), normal tissue myocardial perfusion (TMP) is less commonly
achieved. TMP has been shown to correlate with early clinical outcomes, but its impact
on long-term mortality is not well defined. Furthermore, the best methodology for
determination of TMP has not been established.
Methods: We analyzed the outcomes of 3,267 patients in the HORIZONS-AMI study
according to final TMP, assessed by angiographic dynamic (Dyn) and densitometric
(Den) methods. Multivariable analysis was performed to identify the independent
influence of TMP grade 2/3 (vs. grade 1/2) on survival.
Results: Dyn TMP 2/3 was achieved in 2,600 patients (79.6%) while Den TMP 2/3
was achieved in 2,483 (76.0%). Mortality was significantly lower in those with Dyn
TMP 2/3 compared to TMP 0/1 at 30 days (1.1% vs. 6.9%, p<0.0001) and at 3 years
(5.1% vs. 11.2%, p<0.0001). Similar results were obtained with Den TMP. Dyn TMP
2/3 was an independent predictor of mortality at both time points (HR [95%CI] = 0.21
[0.12, 0.37], p<0.0001 and 0.53 [0.38, 0.73], p<0.0001 respectively, Fig.), as was Den
TMP. Survival was comparable in patients with TMP 2 and TMP 3.
Conclusion: Angiographic TMP can be assessed reliably using either Dyn or Den
methods, and is a powerful, independent predictor of early and late mortality after
primary PCI in STEMI. These data suggest TMP rates may be considered as a quality
metric for assessing individual or hospital primary PCI outcomes.
TCT-617
Noninvasive Assessment of In-Stent Restenosis by High Definition Computed
Tomography Coronary Angiography with New Gemstone Detector
Hirotsugu Mihara, Masaaki Kanashiro, Takuma Tsuda, Yusuke Miki, Toshijirou Aoki,
Takayuki Mitsuda, Shinji Hayano, Susumu Suzuki, Toru Aoyama, Junji Watanabe,
Satoshi Ichimiya
Yokkaichi Municipal Hospital, Yokkaichi, MIE, Japan
Background: Noninvasive assessment of in-stent restenosis (ISR) by computed
tomography coronary angiography has been challenging. Recently high definition
computed tomography (HDCT) coronary angiography with new gemstone detector
has been developed, which has high spatial resolution, so it may lead to significant
improvement of accuracy to diagnose ISR. The purpose of this study is to assess ISR
using HDCT coronary angiography.
Methods: We enrolled consecutive 160 patients with previous coronary stent
implantation who were received HDCT coronary angiography for clinical indications.
HDCT coronary angiography studies were performed using a HDCT (GE Discovery
CT750 HD). Image quality for the evaluation of ISR was assessed using 5-point
grading scale: IQ score (1=excellent, 5=non-assessable). Significant ISR was defined
as >50% luminal narrowing in the stent lumen or the presence of significant stent edge
stenosis.
Results: 313 stents (average diameter 3.0±0.5mm) were evaluated. Image quality was
good on average (IQ score 2.4±1.0). A total of 39 stents (12%) were of nondiagnostic
image quality (IQ score 4 or 5) (feasibility 88%). In 109 stents compared with ICA,
sensitivity, specificity, positive predictive value, and negative predictive value were
100%, 99%, 95%, 100%, respectively, when excluding unassessable stents. There was
104 stents, including 87 silorimus-eluting stents, with diameters of <2.5mm, and 75%
was assessable (IQ score 2.8±1.1).
Conclusion: HDCT coronary angiography with new gemstone detector allows accurate
noninvasive assessment of significant ISR. Noninvasive assessment of ISR using
HDCT could be attractive and feasible alternative.
TCT-618
Quantitative Monitoring of Atherosclerotic Plaque Development and
Characterization by Flat-Panel Computed Tomography
Ibrahim Aboshady1, 2, Dianna D Cody3, Evan M Johnson2, Deborah Vela1, 2, Kamal G
Khalil2, 4, James T Willerson1, 2, L. Maximilian Buja2, 1, Gregory W Gladish3
1Cardiovascular Pathology, Texas Heart Institute, Houston, TX; 2University of Texas
HSC, Houston, TX; 3MD Anderson Cancer Center, Houston, TX; 4Baylor College of
Medicine, Houston, TX
Background: Background: Flat-panel computed tomography (FpCT) provides better
spatial resolution than 64-channel CT and better assesses atherosclerotic plaque
components in vivo in animal aortas similar in size to human coronary arteries. We
assessed the usefulness of FpCT in longitudinal studies of plaque development.
Methods: We used a prototype FpCT scanner with a dual-panel rotating gantry and a
commercial Performix CT x-ray source. Lesions in 184 aortic histology sections from
6 WHHL rabbits were quantitatively compared with 64-CT (image thickness, 0.625
mm) and FpCT (image thickness, 0.150 mm) images. In the current, long-term phase
of the study, 30 NZW hyperlipidemic rabbits receive a high-fat diet (0.5% cholesterol).
Lesions are monitored and correlated through monthly serial scanning sessions over 6
months. Images are collected 30 seconds after Visipaque injection (560 mgI/kg;
through an ear vein) by using 500 views per rotation. Lesions are quantitatively
monitored, and each plaque component is compared.
Results: Although FpCT was more sensitive in detecting eccentric lesions (42% vs
0%; P=0.000), the area under the curve (AUC) for FpCT (0.6) did not significantly
differ from that for 64-CT (0.45; P=NS). In detecting plaques with ≤10% lipid (low-
attenuation foci), FpCT was more sensitive than 64-CT (24% vs 0.7%; P<0.00) and
had a greater AUC (0.6 vs 0.5; P<0.006). Additionally, FpCT was more sensitive (65%
vs 0%; P<0.00) in detecting plaques with ≤5% calcium (high-attenuation foci) but not
in detecting branch points. Both FpCT and histology could detect low-attenuation foci
as small as 0.3 mm in diameter, whereas 64-CT could detect only low-attenuation foci
≥1.5 mm in diameter.
Conclusion: FpCT seems to have more potential in quantitative screening for low-risk
small atherosclerotic lesions, whereas 64-CT is limited to imaging established, well-
characterized lesions, particularly when measuring the vascular wall thickness in a
rabbit model of atherosclerosis. FpCT seems to have potential for quantitatively
monitoring the evolution of calcific and lipid components of plaque
TCT-619
Direct Mapping and Digital Reconstructions Of the Human Cardiac Venous
Anatomy
Julianne Eggum, Scott A Skorupa, Paul A Iaizzo
University of Minnesota, Minneapolis, MN
Background: It is important to identify and understand variations in the anatomy of
the human cardiac venous system in order to best develop and then use minimally
invasive cardiac devices. Hence, anatomical mapping of the cardiac venous system of
a large sampling of human heart specimens, with and without disease, will be a
beneficial aid for cardiac device designers.
Methods: We utilized fluoroscopy, a Microscribe 3Dx Digitizer (Ghost 3D, Castro
Valley CA) and Imageware Software (Siemens, Plano TX) to obtain maps of the cardiac
veins and to create 3D models. To date, we have created models for and taken
anatomical measurements for 18 perfusion fixed human hearts.
Results: We have created a unique anatomical database for the major cardiac veins
that include vessel diameters, arc lengths, tortuousities, and branching angles from the
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coronary sinus. Table 1 summarizes the mean anatomical measurements achieved from
the major veins of 18 human hearts. The veins are labeled as follows: Posterior
Interventricular Vein (PIV), Posterior Vein (PV), Postero-Lateral Vein (PLV), Lateral
Vein (LV), Antero-Lateral Vein (ALV), and Anterior Interventricular Vein (AIV).
Standard deviation, maximum, and minimum parameters were also taken.
Table 1: Mean anatomical parameters for 18 human cardiac venous systems
Conclusion: This novel database of cardiac venous anatomical parameters will allow
one to better visualize and understand the degree of anatomical variability that exists
between human hearts. We will continue to build this data set, which should be of great
value for both device designers and those clinically implanting cardiac devices.
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TCT-621
Long-term (5 years) Serial in vivo Evaluation of Chronic Stent Recoil after
Drug-Elutig Stent Implantation: Does it exits?
Carlos Adolfo Collet, Jose R Costa, Alexandre Abizaid, Fausto Feres, Juan S Munoz,
Ricardo Costa, Daniel Chamie, Dimitry Siqueira, Amanda Sousa, Rodolfo Staico,
Jose E Sousa
Dante Pazzanese Institute Of Cardiology, Sao Paulo, Brazil
Background: Radial expansion and scaffold properties of stainless steel stents
improved acute and mid-term outcomes of coronary angioplasty. However, late stent
recoil has been proposed as one of the possible mechanisms of in-stent restenosis. We
sought to investigate the temporal course of stent expansion using serial intravascular
ultrasound (IVUS) after stainless steel drug-eluting stent (DES) implantation.
Methods: Twenty-two patients with single de novo coronary lesions were treated with
DES with stainless steel platform (10 Cypher and 12 Biomatrix) and underwent
intravascular ultrasound at post-procedure, 9-month and 5 years after implantation. We
only included patients with at least three serial IVUS acquisitions (post procedure, mid
and very long-term). The primary endpoint was the comparison of stent volume and
stent volume index between index procedure, mid and very long-term follow-up.
Results: The mean age was 59 years, with 28% of diabetes mellitus. Stable coronary
syndrome was the initial clinical indication for the majority of the cases (88%). Stent
volume and stent volume index (SVI) were not significantly different between post-
procedure and very-long term follow-up (stent volume 140.6 ± 39.1 mm3 vs. 139.9 ±
32.7 mm3, p=0.88 and SVI 7.7 ± 1.5 mm3/mm vs. 7.8 ± 1.6 mm3/mm, p=0.77). Vessel
volume index also did not significantly changed between post-procedure and long-
term follow-up (16.4 ± 4.7 mm3/mm vs. 15.1 ± 3.6 mm3/mm, p=0.28) with a low
5-year neointinal hyperplasia percent volume of obstruction (4.8%). Regarding
incomplete stent apposition (ISA), 2 cases were observed at the index procedure and
persisted until the last evaluation. There were no cases of acquired ISA.
Conclusion: The present serial IVUS assessment represents the longest serial
evaluation of late stent expansion. There was no evidence of in vivo chronic stent recoil
after stainless steel drug-eluting stent implantation.
TCT-622
The Clinical Impact of Intravascular Ultrasound in Patients Undergoing
Implantation of Drug-eluting Stents in the Left Main
Abdi Jama, Federico Conrotto, Ryan Lennon, Amir Lerman
Cardiology, Mayo Clinic, Rochester, MN
Background: The clinical utility of intravascular ultrasound during left main stenting
with drug-eluting stents (DES) has not been well understood. We sought to determine
if the use of intravascular ultrasound during left main stenting with DES in high risk
patients yields future clinical benefit in terms of survival, and reduction in recurrent
myocardial infarction (MI) and revascularization.
Methods: Medical records of 624 patients who underwent left main coronary stenting
between August 1990 and November 2010 at Mayo Clinic were reviewed. 329 patients
who had implantation of bare metal stents were excluded. 111 patients who had
intravascular ultrasound performed during DES stenting of the left main were
compared with 184 patients with conventional angiography and stenting. Of the 295
patients with implantation of DES into the left main, 100 had unprotected left main
disease. Information was collected on patient characteristics, comorbidities,
presentation, ejection fraction, recurrent MI, target lesion and target vessel
revascularization and mortality. The primary end point was mortality. Secondary end
points were revascularization and MI.
Results: The two groups were well matched for clinical and angiographic
characteristics. Patients undergoing IVUS during DES implantation were less likely
to have had coronary artery bypass surgery, underwent more direct stenting, post-
dilatation, and had shorter stent length. At three years, there was no difference in
survival between the IVUS and NO IVUS group (15.8 vs.13.3%, p=0.833). There was
no difference in revascularization (17.7 vs. 20.6%, p=0.994) between the groups. There
was a trend towards increased MI in the IVUS compared to the NO IVUS group
although not statistically significant (11.5% vs 5.3%, p=0.073). Among the 100 patients
with unprotect left main and DES stenting; there were no difference in mortality,
revascularization and MI between the groups.
Conclusion: Utilization of intravascular ultrasound during implantation of DES into
the left main might not improve long-term mortality or reduce recurrent MI and
revascularization.
TCT-623
Intravascular Ultrasound and Optical Coherence Tomography Comparison of
the Self-expanding Sideguard Stent in the Sidebranch Versus a Balloon-
Expandable Drug-Eluting Stent in the Main Vessel: Follow-up Results of
Bifurcation Lesions Treated with this Novel Approach
Shixin Ma1, Akiko Maehara1, Karl E Hauptmann2, Giulio Guagliumi3, Orazio
Valsecchi3, Angelina Vassileva3, Yolande Appelman4, Giuseppe Sangiorgi5,
Francesco Prati6, Gary S Mintz1
1Cardiovascular Research Foundation, New York, NY; 2Bruderkrankenhaus, TRIER,
Germany; 3Ospedali Riuniti di Bergamo, DI BERGAMO, Italy; 4VU Medical Centre,
AMSTERDAM, Netherlands; 5University Hospital, MODENA, Italy; 6San Giovanni
Hospital, ROME, Italy
Background: The Cappella Sideguard sidebranch (SB) stent is a self-expanding, thin-
strut, nitinol device with anatomic flaring at the SB ostium.
Methods: We performed intravascular ultrasound (IVUS) post-intervention and IVUS
(n=28) and OCT (n=12) at follow-up and compared serial changes between the
Cappella Sideguard stent in the SB and a balloon-expandable drug-eluting stent (DES)
in the corresponding main vessel (MV).
Results: 1. Cappella Sideguard stent carinal area increased from 3.9±1.3mm2 post-
intervention to 4.6±1.3mm2 at follow-up (p<0.001) that led no change in lumen area
(3.9±1.3 to 3.8±1.2mm2, p=0.7) despite a neointimal hyperplasia (NIH) area of
0.8±0.8mm2. 2. Compared to the MV, in the SB there was a larger NIH volume and a
significant increase in stent (4.9±3.6 vs 0.3±3.0mm3, p<0.001) and vessel volumes,
with no difference in Δlumen volume. 3. NIH peaked 1-2mm distal to the carina
(Figure). 4. Using OCTNIH thickness at the SB side of the bifurcation was greater
than at the MV side, the percentage of uncovered struts was less (2.9% at SB vs 12.7%
at MV, p<0.001), and 61% of floating stent struts at the carina were covered by smooth
tissue.
Conclusion: The self-expanding Cappella Sideguard stent maintains an adequate
lumen, especially at the SB carina at follow-up, with NIH accumulation mainly 1~2mm
distal to the carina that correlates to the increase in stent dimensions.
TCT-624
Comparison by Optical Frequency-Domain Imaging of Paclitaxel-Eluting
Stents and Everolimus-Eluting Stents Implanted in One Coronary Artery in
One Procedure. A 12 Months Follow Up Evaluation
Jose M De la Torre Hernandez, Dae-Hyun Lee, Tamara Garcia Camarero, Piedad
Lerena, Gonzalo Martin Gorria, Fermin Sainz Laso, Javier Zueco
Hemodinamica, Hospital U. Marques de Valdecilla, Santander, Spain
Background: Optical frequency-domain imaging (OFDI) allows a detailed assessment
of intimal coverage and strut apposition which are factors well known associated with
late thrombosis. This study seeks to asses and compare long term intimal coverage and
stent apposition with paclitaxel-eluting stents (PES) Taxus Liberte TM and everolimus-
eluting stents (EES) Xience Prime TM.
Methods: We have applied a particular clinical model, that of a same patient with two
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